$cno 2023 Q1 10-K

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.021B	$973.6M	$3.577B
YoY Change	21.08%	-9.42%	-13.23%
Cost Of Revenue	$609.7M		$1.658B
YoY Change	75.86%		-24.3%
Gross Profit	$410.9M		$1.919B
YoY Change	-17.19%		-0.67%
Gross Profit Margin	40.26%		53.64%
Selling, General & Admin			$405.8M
YoY Change			5.59%
% of Gross Profit			21.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$65.70M		$345.3M
YoY Change	-41.7%		8.08%
% of Gross Profit	15.99%		18.0%
Operating Expenses	$937.5M	$870.4M	$2.923B
YoY Change	39.97%	-3.62%	-15.51%
Operating Profit	$76.40M		$357.1M
YoY Change	12.35%		-24.12%
Interest Expense	-$69.50M	-$47.80M	$137.0M
YoY Change	-392.02%	102.54%	43.61%
% of Operating Profit	-90.97%		38.36%
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.000M	$55.40M	$517.3M
YoY Change	-100.67%	-62.59%	-8.88%
Income Tax	-$200.0K	$12.00M	$120.5M
% Of Pretax Income		21.66%	23.29%
Net Earnings	-$800.0K	$43.40M	$396.8M
YoY Change	-100.71%	-62.52%	-10.02%
Net Earnings / Revenue	-0.08%	4.46%	11.09%
Basic Earnings Per Share	-$0.01	$0.38	$3.43
Diluted Earnings Per Share	-$0.01	$0.37	$3.37
COMMON SHARES
Basic Shares Outstanding	114.2M shares	114.4M shares	115.7M shares
Diluted Shares Outstanding	114.5M shares		117.7M shares

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$522.1M	$644.9M	$644.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment		$46.60M	$46.60M
YoY Change			-3.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$25.34B	$24.34B	$24.34B
YoY Change	-7.63%	-15.85%	-15.85%
Other Assets	$988.1M	$1.166B	$1.166B
YoY Change	84.97%	885.21%	885.21%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$34.02B	$33.34B	$33.34B
YoY Change	-4.1%	-7.91%	-7.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses			$49.60M
YoY Change			-5.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities			$49.60M
YoY Change			-5.16%
LONG-TERM LIABILITIES
Long-Term Debt	$4.044B	$3.883B	$3.883B
YoY Change	3.4%	-2.95%	-2.95%
Other Long-Term Liabilities	$698.9M	$693.9M	$644.3M
YoY Change	-23.39%	-16.49%	-17.25%
Total Long-Term Liabilities	$4.743B	$4.577B	$4.527B
YoY Change	-1.67%	-5.28%	-5.28%
TOTAL LIABILITIES
Total Short-Term Liabilities			$49.60M
Total Long-Term Liabilities	$4.743B	$4.577B	$4.527B
Total Liabilities	$31.98B	$31.94B	$31.94B
YoY Change	0.65%	3.21%	3.21%
SHAREHOLDERS EQUITY
Retained Earnings	$1.674B	$1.459B
YoY Change	36.82%	29.44%
Common Stock	$2.022B	$2.035B
YoY Change	-3.1%	-6.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.032B	$1.401B	$1.401B
YoY Change
Total Liabilities & Shareholders Equity	$34.02B	$33.34B	$33.34B
YoY Change	-4.1%	-7.91%	-7.91%

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$800.0K	$43.40M	$396.8M
YoY Change	-100.71%	-62.52%	-10.02%
Depreciation, Depletion And Amortization	$65.70M		$345.3M
YoY Change	-41.7%		8.08%
Cash From Operating Activities	$81.90M	$160.9M	$495.4M
YoY Change	45.21%	34.87%	-17.2%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$13.90M	-$213.4M	$61.20M
YoY Change	4.51%	-70.8%	-18.73%
Cash From Investing Activities	-$406.7M	-$213.4M	-$1.781B
YoY Change	-59.74%	-70.8%	16.72%
FINANCING ACTIVITIES
Cash Dividend Paid	$17.10M		$64.80M
YoY Change	6.21%		-1.37%
Common Stock Issuance & Retirement, Net			$176.6M
YoY Change			-54.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$202.0M	143.9M	$1.199B
YoY Change	-75.25%	-72.87%	79.61%
NET CHANGE
Cash From Operating Activities	$81.90M	160.9M	$495.4M
Cash From Investing Activities	-$406.7M	-213.4M	-$1.781B
Cash From Financing Activities	$202.0M	143.9M	$1.199B
Net Change In Cash	-$122.8M	91.40M	-$86.80M
YoY Change	-10.82%	-212.98%	-66.64%
FREE CASH FLOW
Cash From Operating Activities	$81.90M	$160.9M	$495.4M
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	cno	Operating Loss Carryforward Limitation Number Of Shares Purchased By Each Right OperatingLossCarryforwardLimitationNumberOfSharesPurchasedByEachRight	0.001	shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-31792
CY2022	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3108137
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	11825 N. Pennsylvania Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel,
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
CY2022	dei	City Area Code CityAreaCode	(317)
CY2022	dei	Local Phone Number LocalPhoneNumber	817-6100
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	2000000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	114220896	shares
CY2022	dei	Auditor Firm AuditorFirmId	238
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Indianapolis, Indiana
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	56000000.0	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	7600000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	23384200000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	21867600000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	20353400000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	24805400000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	135300000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	131100000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8000000.0	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5600000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1411900000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1218600000	usd
CY2022Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	121600000	usd
CY2021Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	120200000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	207900000	usd
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	227200000	usd
CY2022Q4	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	5500000	usd
CY2021Q4	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	3700000	usd
CY2022Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1134200000	usd
CY2021Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1206800000	usd
CY2022Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1077600000	usd
CY2021Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1199600000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1034700000	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	1224000000	usd
CY2022Q4	us-gaap	Investments Investments	24342400000	usd
CY2021Q4	us-gaap	Investments Investments	28926100000	usd
CY2022Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	575700000	usd
CY2021Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	632100000	usd
CY2022Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	69200000	usd
CY2021Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	99600000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	235600000	usd
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	216400000	usd
CY2022Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	212200000	usd
CY2021Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	222600000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1913400000	usd
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1112000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	2000000.0	usd
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	3000000.0	usd
CY2022Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4241700000	usd
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4354300000	usd
CY2022Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	1165500000	usd
CY2021Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	118300000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	2700000	usd
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	3900000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	580800000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	519100000	usd
CY2022Q4	us-gaap	Assets Assets	33339200000	usd
CY2021Q4	us-gaap	Assets Assets	36204400000	usd
CY2022Q4	us-gaap	Policyholder Funds PolicyholderFunds	14858300000	usd
CY2021Q4	us-gaap	Policyholder Funds PolicyholderFunds	13689700000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11809100000	usd
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11670700000	usd
CY2022Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	456500000	usd
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	501800000	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	235000000.0	usd
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	246700000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	2700000	usd
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3900000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	693900000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	830900000	usd
CY2022Q4	cno	Investment Borrowings InvestmentBorrowings	1639500000	usd
CY2021Q4	cno	Investment Borrowings InvestmentBorrowings	1715800000	usd
CY2022Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1104600000	usd
CY2021Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1147900000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1138800000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	1137300000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31938400000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	30944700000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	114343070	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	114343070	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120377152	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120377152	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1100000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1200000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2033800000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2184200000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2093100000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1947100000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1459000000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1127200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1400800000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5259700000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33339200000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36204400000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	2499800000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	2523400000	usd
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	2511300000	usd
CY2022	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1179000000	usd
CY2021	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1140200000	usd
CY2020	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1079000000	usd
CY2022	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	-163100000	usd
CY2021	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	280500000	usd
CY2020	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	143500000	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-17900000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	21300000	usd
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-18400000	usd
CY2022	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-117500000	usd
CY2021	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-2200000	usd
CY2020	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-17800000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-135400000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	usd
CY2022	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	196500000	usd
CY2021	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	159000000.0	usd
CY2020	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	123500000	usd
CY2022	us-gaap	Revenues Revenues	3576800000	usd
CY2021	us-gaap	Revenues Revenues	4122200000	usd
CY2020	us-gaap	Revenues Revenues	3821100000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1658300000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2190700000	usd
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2157900000	usd
CY2022	us-gaap	Interest Expense InterestExpense	137000000.0	usd
CY2021	us-gaap	Interest Expense InterestExpense	95400000	usd
CY2020	us-gaap	Interest Expense InterestExpense	108800000	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	309600000	usd
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	281100000	usd
CY2020	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	268100000	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	954600000	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	987300000	usd
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	942000000.0	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3059500000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3554500000	usd
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3476800000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	517300000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	567700000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	344300000	usd
CY2022	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	120500000	usd
CY2021	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	126700000	usd
CY2020	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	76500000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	396800000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115733000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128400000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142096000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.43
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.43
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.12
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117717000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131126000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143164000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.37
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2022	us-gaap	Net Income Loss NetIncomeLoss	396800000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-6028400000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-486700000	usd
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1332800000	usd
CY2022	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-632300000	usd
CY2021	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-35500000	usd
CY2020	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	116000000.0	usd
CY2022	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	165000000.0	usd
CY2021	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	174500000	usd
CY2020	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-204000000.0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-60500000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	29400000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-27100000	usd
CY2022	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-3400000	usd
CY2021	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	1700000	usd
CY2020	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-2400000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-5174000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-304400000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1037500000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-1133800000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-65400000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	223900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4040200000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-239000000.0	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	813600000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3643400000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	202000000.0	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1115400000	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	usd
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	223900000	usd
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	813600000	usd
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	263000000.0	usd
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	67400000	usd
CY2020	cno	Stock Based Compensation StockBasedCompensation	40000000.0	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5484200000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-65400000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-239000000.0	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	402400000	usd
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	66100000	usd
CY2021	cno	Stock Based Compensation StockBasedCompensation	42000000.0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5259700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	396800000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1133800000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4040200000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	180000000.0	usd
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	65000000.0	usd
CY2022	cno	Stock Based Compensation StockBasedCompensation	29500000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1400800000	usd
CY2022	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2300200000	usd
CY2021	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2341800000	usd
CY2020	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2331000000	usd
CY2022	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1154500000	usd
CY2021	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1073100000	usd
CY2020	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1097400000	usd
CY2022	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	149200000	usd
CY2021	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	142500000	usd
CY2020	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	123500000	usd
CY2022	cno	Insurance Policy Benefits InsurancePolicyBenefits	1635800000	usd
CY2021	cno	Insurance Policy Benefits InsurancePolicyBenefits	1661100000	usd
CY2020	cno	Insurance Policy Benefits InsurancePolicyBenefits	1582900000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	120900000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	92800000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	111200000	usd
CY2022	cno	Policy Acquisition Costs PolicyAcquisitionCosts	332200000	usd
CY2021	cno	Policy Acquisition Costs PolicyAcquisitionCosts	298800000	usd
CY2020	cno	Policy Acquisition Costs PolicyAcquisitionCosts	275800000	usd
CY2022	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	985700000	usd
CY2021	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	926200000	usd
CY2020	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	818100000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	33900000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-19800000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	28400000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	495400000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	598300000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	735500000	usd
CY2022	cno	Sales Of Investments SalesOfInvestments	3253600000	usd
CY2021	cno	Sales Of Investments SalesOfInvestments	1823600000	usd
CY2020	cno	Sales Of Investments SalesOfInvestments	1480000000	usd
CY2022	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1550700000	usd
CY2021	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2880300000	usd
CY2020	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2218300000	usd
CY2022	cno	Purchases Of Investments PurchasesOfInvestments	6482000000	usd
CY2021	cno	Purchases Of Investments PurchasesOfInvestments	6135200000	usd
CY2020	cno	Purchases Of Investments PurchasesOfInvestments	4280700000	usd
CY2022	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-42400000	usd
CY2021	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-19500000	usd
CY2020	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	13800000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	61200000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	75300000	usd
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	39800000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1781300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1526100000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-608400000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	145800000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13500000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21500000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19000000.0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	190100000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	407800000	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	268300000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	64800000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	65700000	usd
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	67000000.0	usd
CY2022	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	3022600000	usd
CY2021	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	2405100000	usd
CY2020	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1620100000	usd
CY2022	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1461400000	usd
CY2021	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1352500000	usd
CY2020	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1235600000	usd
CY2022	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	285000000.0	usd
CY2021	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	795800000	usd
CY2020	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	498000000.0	usd
CY2022	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	361300000	usd
CY2021	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	722400000	usd
CY2020	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	499800000	usd
CY2022	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	44400000	usd
CY2021	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	5400000	usd
CY2020	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	2100000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000000.0	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1199100000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	667600000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210100000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-86800000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-260200000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	337200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	731700000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991900000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	654700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	644900000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	731700000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991900000	usd
CY2022	cno	Discount Rate Used To Determine Present Value Of Future Insurance Profits DiscountRateUsedToDeterminePresentValueOfFutureInsuranceProfits	0.12
CY2022	us-gaap	Ceded Premiums Written CededPremiumsWritten	206200000	usd
CY2021	us-gaap	Ceded Premiums Written CededPremiumsWritten	222400000	usd
CY2020	us-gaap	Ceded Premiums Written CededPremiumsWritten	239500000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	361400000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	310900000	usd
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	403800000	usd
CY2022	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	18700000	usd
CY2021	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	20300000	usd
CY2020	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	23000000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	25000000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	24900000	usd
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	31400000	usd
CY2022Q4	cno	Investments Held In Limited Partnerships And Hedge Funds InvestmentsHeldInLimitedPartnershipsAndHedgeFunds	588900000	usd
CY2022Q4	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	441200000	usd
CY2022	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
CY2022	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	33500000	usd
CY2021	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	9800000	usd
CY2020	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	21200000	usd
CY2022	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed indexed annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. We are generally able to change the participation rate at the beginning of each index period (typically on each policy anniversary date), subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed indexed annuity products at estimated fair value. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivative is based on the estimated cost to fulfill our commitment to fixed indexed annuity policyholders to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. In valuing these options, we are required to make assumptions regarding: (i) future index values to determine both the future notional amounts at each anniversary date and the future prices of the forward starting options; (ii) future annual participation rates; and (iii) non-economic factors related to policy persistency. These assumptions are used to estimate the future cost to purchase the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and risk margins for non-capital market inputs. The non-performance risk adjustment is determined by taking into consideration publicly available information related to spreads in the secondary market for debt with credit ratings similar to ours. These observable spreads are then adjusted to reflect the priority of these liabilities and the claim paying ability of the issuing insurance subsidiaries.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk margins are established to capture non-capital market risks which represent the additional compensation a market participant would require to assume the risks related to the uncertainties regarding the embedded derivatives, including future policyholder behavior related to persistency. The determination of the risk margin is highly judgmental given the lack of a market to assume the risks solely related to the embedded derivatives of our fixed indexed annuity products.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the appropriate risk-free rate and non-performance risk is sensitive to the economic and interest rate environment. Accordingly, the value of the derivative is volatile due to external market sensitivities, which may materially affect net income. Additionally, changes in the judgmental assumptions regarding the appropriate risk margin can significantly impact the value of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.</span></div>
CY2022	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	22500000	usd
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	17300000	usd
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	14100000	usd
CY2022	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	17800000	usd
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	15500000	usd
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	15400000	usd
CY2022Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	65900000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	61200000	usd
CY2020Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	21293100000	usd
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1559400000	usd
CY2020Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1178700000	usd
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	437500000	usd
CY2020Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4781700000	usd
CY2020Q1	us-gaap	Assets Assets	33613100000	usd
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	517900000	usd
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	4659200000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	23384200000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	20353400000	usd
CY2022Q4	cno	Available For Sale Securities Fair Value Disclosure Percentage Of Estimated Fair Value AvailableForSaleSecuritiesFairValueDisclosurePercentageOfEstimatedFairValue	1.000
CY2022Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	-1247000000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	2963300000	usd
CY2022Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-1780700000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-23100000	usd
CY2022Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	8200000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-8300000	usd
CY2022Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	331700000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-420200000	usd
CY2022Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	0	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-25500000	usd
CY2022Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	594700000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-539100000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2093100000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1947100000	usd
CY2021Q4	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-7300000	usd
CY2021Q4	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-132200000	usd
CY2021Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-25500000	usd
CY2021Q4	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	35800000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	112000000.0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	110800000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1913700000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1790200000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	2098900000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1910400000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	12629400000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10523200000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	16754000000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	14334600000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	6630200000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	6018800000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	23384200000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	20353400000	usd
CY2022	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	1084100000	usd
CY2021	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	962600000	usd
CY2020	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	924800000	usd
CY2022	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	5900000	usd
CY2021	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	4300000	usd
CY2020	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	3000000.0	usd
CY2022	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	63000000.0	usd
CY2021	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	65000000.0	usd
CY2020	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	79500000	usd
CY2022	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8400000	usd
CY2021	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8200000	usd
CY2020	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8500000	usd
CY2022	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	38000000.0	usd
CY2021	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	124800000	usd
CY2020	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	84000000.0	usd
CY2022	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	5900000	usd
CY2021	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	300000	usd
CY2020	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	2600000	usd
CY2022	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	7700000	usd
CY2021	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	7200000	usd
CY2020	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	28100000	usd
CY2022	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	-6300000	usd
CY2021	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	212000000.0	usd
CY2020	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	35000000.0	usd
CY2022	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	-200300000	usd
CY2021	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	8900000	usd
CY2020	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	4500000	usd
CY2022	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	35800000	usd
CY2021	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	52400000	usd
CY2020	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	75900000	usd
CY2022	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1042200000	usd
CY2021	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1445700000	usd
CY2020	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1245900000	usd
CY2022	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	26300000	usd
CY2021	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	25000000.0	usd
CY2020	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	23400000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	1015900000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1420700000	usd
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1222500000	usd
CY2022Q4	cno	Carrying Value Of Fixed Maturity Investments Not Accruing Investment Income CarryingValueOfFixedMaturityInvestmentsNotAccruingInvestmentIncome	1000000	usd
CY2022Q4	cno	Carrying Value Mortgage Loans Not Accruing Investment Income CarryingValueMortgageLoansNotAccruingInvestmentIncome	0	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-17900000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	21300000	usd
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-18400000	usd
CY2022	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	52600000	usd
CY2021	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-12200000	usd
CY2020	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	18500000	usd
CY2022	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-2900000	usd
CY2021	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-7300000	usd
CY2020	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-1800000	usd
CY2022	cno	Increase Decrease In Fair Value Of Other Securities IncreaseDecreaseInFairValueOfOtherSecurities	-62000000.0	usd
CY2021	cno	Increase Decrease In Fair Value Of Other Securities IncreaseDecreaseInFairValueOfOtherSecurities	-7100000	usd
CY2020	cno	Increase Decrease In Fair Value Of Other Securities IncreaseDecreaseInFairValueOfOtherSecurities	2500000	usd
CY2022	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-117500000	usd
CY2021	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-2200000	usd
CY2020	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-17800000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-135400000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	usd
CY2022	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	-1800000	usd
CY2021	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	11400000	usd
CY2020	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	-5200000	usd
CY2022	cno	Increase Decrease In Equity Securities Fvni Held At End Of Period IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod	-7300000	usd
CY2021	cno	Increase Decrease In Equity Securities Fvni Held At End Of Period IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod	-7800000	usd
CY2020	cno	Increase Decrease In Equity Securities Fvni Held At End Of Period IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod	-1700000	usd
CY2022	us-gaap	Increase Decrease In Debt Securities Trading IncreaseDecreaseInDebtSecuritiesTrading	-43300000	usd
CY2021	us-gaap	Increase Decrease In Debt Securities Trading IncreaseDecreaseInDebtSecuritiesTrading	-3100000	usd
CY2020	us-gaap	Increase Decrease In Debt Securities Trading IncreaseDecreaseInDebtSecuritiesTrading	400000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-135400000	usd
CY2022	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	52600000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	usd
CY2021	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-12200000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	usd
CY2020	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	18500000	usd
CY2022Q4	cno	Numberof Investmentsin Defaultor Considered Nonperforming NumberofInvestmentsinDefaultorConsideredNonperforming	0	investment
CY2022	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	1651500000	usd
CY2021	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	493500000	usd
CY2020	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	507100000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Within One Year Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBasisWithUnrealizedLosses	91200000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Within One Year Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueWithUnrealizedLosses	89800000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBasisWithUnrealizedLosses	1741900000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueWithUnrealizedLosses	1615500000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBasisWithUnrealizedLosses	1845300000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueWithUnrealizedLosses	1649800000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBasisWithUnrealizedLosses	11631200000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities After Ten Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueWithUnrealizedLosses	9485800000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost With Unrealized Losses Subtotal AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostWithUnrealizedLossesSubtotal	15309600000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Subtotal AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesSubtotal	12840900000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBasisWithUnrealizedLosses	6040100000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueWithUnrealizedLosses	5385900000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Basis With Unrealized Losses Total AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisWithUnrealizedLossesTotal	21349700000	usd
CY2022Q4	cno	Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Total AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesTotal	18226800000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	7636900000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	835200000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1897500000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	471600000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	9534400000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1306800000	usd

CY2022

dei

Entity Central Index Key

EntityCentralIndexKey

0001224608

CY2022

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2022

CY2022

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2022

dei

Amendment Flag

AmendmentFlag

false

CY2019

us-gaap

Accounting Standards Update Extensible List

AccountingStandardsUpdateExtensibleList

http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member

CY2021Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2022#OtherAssets

CY2022Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2022#OtherAssets

CY2022Q4

us-gaap

Operating Lease Liability Statement Of Financial Position Extensible List

OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2022#OtherLiabilities

CY2021Q4

us-gaap

Operating Lease Liability Statement Of Financial Position Extensible List

OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2022#OtherLiabilities

CY2022Q4

cno

Operating Loss Carryforward Limitation Number Of Shares Purchased By Each Right

OperatingLossCarryforwardLimitationNumberOfSharesPurchasedByEachRight

0.001

shares

CY2022

dei

Document Type

DocumentType

10-K

CY2022

dei

Document Annual Report

DocumentAnnualReport

true

CY2022

dei

Document Period End Date

DocumentPeriodEndDate

2022-12-31

CY2022

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2022

dei

Document Transition Report

DocumentTransitionReport

false

CY2022

dei

Entity File Number

EntityFileNumber

001-31792

CY2022

dei

Entity Registrant Name

EntityRegistrantName

CNO Financial Group, Inc.

CY2022

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2022

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

75-3108137

CY2022

dei

Entity Address Address Line1

EntityAddressAddressLine1

11825 N. Pennsylvania Street

CY2022

dei

Entity Address City Or Town

EntityAddressCityOrTown

Carmel,

CY2022

dei

Entity Address State Or Province

EntityAddressStateOrProvince

IN

CY2022

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

46032

CY2022

dei

City Area Code

CityAreaCode

(317)

CY2022

dei

Local Phone Number

LocalPhoneNumber

817-6100

CY2022

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2022

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2022

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2022

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2022

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2022

dei

Entity Small Business

EntitySmallBusiness

false

CY2022

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2022

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2022

dei

Entity Shell Company

EntityShellCompany

false

CY2022Q2

dei

Entity Public Float

EntityPublicFloat

2000000000

usd

CY2023Q1

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

114220896

shares

CY2022

dei

Auditor Firm

AuditorFirmId

238

CY2022

dei

Auditor Name

AuditorName

PricewaterhouseCoopers LLP

CY2022

dei

Auditor Location

AuditorLocation

Indianapolis, Indiana

CY2022Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

56000000.0

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

7600000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss

23384200000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss

21867600000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

20353400000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

24805400000

usd

CY2022Q4

us-gaap

Equity Securities Fv Ni

EquitySecuritiesFvNi

135300000

usd

CY2021Q4

us-gaap

Equity Securities Fv Ni

EquitySecuritiesFvNi

131100000

usd

CY2022Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

8000000.0

usd

CY2021Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

5600000

usd

CY2022Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

1411900000

usd

CY2021Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

1218600000

usd

CY2022Q4

us-gaap

Policy Loans Receivable

PolicyLoansReceivable

121600000

usd

CY2021Q4

us-gaap

Policy Loans Receivable

PolicyLoansReceivable

120200000

usd

CY2022Q4

us-gaap

Trading Securities Debt

TradingSecuritiesDebt

207900000

usd

CY2021Q4

us-gaap

Trading Securities Debt

TradingSecuritiesDebt

227200000

usd

CY2022Q4

cno

Investments Held By Variable Interest Entities Allowance For Credit Loss

InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss

5500000

usd

CY2021Q4

cno

Investments Held By Variable Interest Entities Allowance For Credit Loss

InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss

3700000

usd

CY2022Q4

cno

Investments Held By Variable Interest Entities Amortized Cost

InvestmentsHeldByVariableInterestEntitiesAmortizedCost

1134200000

usd

CY2021Q4

cno

Investments Held By Variable Interest Entities Amortized Cost

InvestmentsHeldByVariableInterestEntitiesAmortizedCost

1206800000

usd

CY2022Q4

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1077600000

usd

CY2021Q4

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1199600000

usd

CY2022Q4

us-gaap

Other Investments

OtherInvestments

1034700000

usd

CY2021Q4

us-gaap

Other Investments

OtherInvestments

1224000000

usd

CY2022Q4

us-gaap

Investments

24342400000

usd

CY2021Q4

us-gaap

Investments

28926100000

usd

CY2022Q4

cno

Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities

CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities

575700000

usd

CY2021Q4

cno

Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities

CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities

632100000

usd

CY2022Q4

cno

Cash And Cash Equivalents Held By Variable Interest Entities

CashAndCashEquivalentsHeldByVariableInterestEntities

69200000

usd

CY2021Q4

cno

Cash And Cash Equivalents Held By Variable Interest Entities

CashAndCashEquivalentsHeldByVariableInterestEntities

99600000

usd

CY2022Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

235600000

usd

CY2021Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

216400000

usd

CY2022Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

212200000

usd

CY2021Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

222600000

usd

CY2022Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1913400000

usd

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1112000000

usd

CY2022Q4

us-gaap

Reinsurance Recoverables Allowance

ReinsuranceRecoverablesAllowance

2000000.0

usd

CY2021Q4

us-gaap

Reinsurance Recoverables Allowance

ReinsuranceRecoverablesAllowance

3000000.0

usd

CY2022Q4

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4241700000

usd

CY2021Q4

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4354300000

usd

CY2022Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

1165500000

usd

CY2021Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

118300000

usd

CY2022Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

2700000

usd

CY2021Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

3900000

usd

CY2022Q4

us-gaap

Other Assets

OtherAssets

580800000

usd

CY2021Q4

us-gaap

Other Assets

OtherAssets

519100000

usd

CY2022Q4

us-gaap

Assets

33339200000

usd

CY2021Q4

us-gaap

Assets

36204400000

usd

CY2022Q4

us-gaap

Policyholder Funds

PolicyholderFunds

14858300000

usd

CY2021Q4

us-gaap

Policyholder Funds

PolicyholderFunds

13689700000

usd

CY2022Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11809100000

usd

CY2021Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11670700000

usd

CY2022Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

456500000

usd

CY2021Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

501800000

usd

CY2022Q4

us-gaap

Unearned Premiums

UnearnedPremiums

235000000.0

usd

CY2021Q4

us-gaap

Unearned Premiums

UnearnedPremiums

246700000

usd

CY2022Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

2700000

usd

CY2021Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

3900000

usd

CY2022Q4

us-gaap

Other Liabilities

OtherLiabilities

693900000

usd

CY2021Q4

us-gaap

Other Liabilities

OtherLiabilities

830900000

usd

CY2022Q4

cno

Investment Borrowings

InvestmentBorrowings

1639500000

usd

CY2021Q4

cno

Investment Borrowings

InvestmentBorrowings

1715800000

usd

CY2022Q4

cno

Borrowings Related To Variable Interest Entities

BorrowingsRelatedToVariableInterestEntities

1104600000

usd

CY2021Q4

cno

Borrowings Related To Variable Interest Entities

BorrowingsRelatedToVariableInterestEntities

1147900000

usd

CY2022Q4

us-gaap

Notes Payable

NotesPayable

1138800000

usd

CY2021Q4

us-gaap

Notes Payable

NotesPayable

1137300000

usd

CY2022Q4

us-gaap

Liabilities

31938400000

usd

CY2021Q4

us-gaap

Liabilities

30944700000

usd

CY2022Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2021Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2021Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2022Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2021Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2022Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

114343070

shares

CY2022Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

114343070

shares

CY2021Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

120377152

shares

CY2021Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

120377152

shares

CY2022Q4

us-gaap

Common Stock Value

CommonStockValue

1100000

usd

CY2021Q4

us-gaap

Common Stock Value

CommonStockValue

1200000

usd

CY2022Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

2033800000

usd

CY2021Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

2184200000

usd

CY2022Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-2093100000

usd

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1947100000

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1459000000

usd

CY2021Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1127200000

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1400800000

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

5259700000

usd

CY2022Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

33339200000

usd

CY2021Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

36204400000

usd

CY2022

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2499800000

usd

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2523400000

usd

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2511300000

usd

CY2022

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1179000000

usd

CY2021

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1140200000

usd

CY2020

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1079000000

usd

CY2022

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

-163100000

usd

CY2021

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

280500000

usd

CY2020

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

143500000

usd

CY2022

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-17900000

usd

CY2021

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

21300000

usd

CY2020

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-18400000

usd

CY2022

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-117500000

usd

CY2021

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-2200000

usd

CY2020

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-17800000

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-135400000

usd

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

usd

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

usd

CY2022

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

196500000

usd

CY2021

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

159000000.0

usd

CY2020

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

123500000

usd

CY2022

us-gaap

Revenues

3576800000

usd

CY2021

us-gaap

Revenues

4122200000

usd

CY2020

us-gaap

Revenues

3821100000

usd

CY2022

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

1658300000

usd

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

2190700000

usd

CY2020

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

2157900000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

137000000.0

usd

CY2021

us-gaap

Interest Expense

InterestExpense

95400000

usd

CY2020

us-gaap

Interest Expense

InterestExpense

108800000

usd

CY2022

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

309600000

usd

CY2021

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

281100000

usd

CY2020

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

268100000

usd

CY2022

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

954600000

usd

CY2021

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

987300000

usd

CY2020

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

942000000.0

usd

CY2022

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3059500000

usd

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3554500000

usd

CY2020

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3476800000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

517300000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

567700000

usd

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

344300000

usd

CY2022

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

120500000

usd

CY2021

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

126700000

usd

CY2020

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

76500000

usd

CY2022

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

usd

CY2021

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

usd

CY2020

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-34000000.0

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

396800000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

usd

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

usd

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

115733000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

128400000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

142096000

shares

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

3.43

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

3.43

CY2020

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.12

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

117717000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

131126000

shares

CY2020

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

143164000

shares

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

3.37

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

3.36

CY2020

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.11

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

396800000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

usd

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

usd

CY2022

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

-6028400000

usd

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

-486700000

usd

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

1332800000

usd

CY2022

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

-632300000

usd

CY2021

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

-35500000

usd

CY2020

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

116000000.0

usd

CY2022

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

165000000.0

usd

CY2021

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

174500000

usd

CY2020

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

-204000000.0

usd

CY2022

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

-60500000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

29400000

usd

CY2020

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

-27100000

usd

CY2022

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

-3400000

usd

CY2021

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

1700000

usd

CY2020

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

-2400000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

-5174000000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

-304400000

usd

CY2020

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

1037500000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

-1133800000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

-65400000

usd

CY2020

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

223900000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-4040200000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-239000000.0

usd

CY2020

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

813600000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-3643400000

usd

CY2021

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

202000000.0

usd

CY2020

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1115400000

usd

CY2019Q4

us-gaap

Stockholders Equity

StockholdersEquity

4677000000

usd

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

usd

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

223900000

usd

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

813600000

usd

CY2020

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

263000000.0

usd

CY2020

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

67400000

usd

CY2020

cno

Stock Based Compensation

StockBasedCompensation

40000000.0

usd

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

5484200000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

usd

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

-65400000

usd

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

-239000000.0

usd

CY2021

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

402400000

usd

CY2021

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

66100000

usd

CY2021

cno

Stock Based Compensation

StockBasedCompensation

42000000.0

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

5259700000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

396800000

usd

CY2022

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

-1133800000

usd

CY2022

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

-4040200000

usd

CY2022

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

180000000.0

usd

CY2022

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

65000000.0

usd

CY2022

cno

Stock Based Compensation

StockBasedCompensation

29500000

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1400800000

usd

CY2022

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2300200000

usd

CY2021

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2341800000

usd

CY2020

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2331000000

usd

CY2022

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1154500000

usd

CY2021

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1073100000

usd

CY2020

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1097400000

usd

CY2022

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

149200000

usd

CY2021

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

142500000

usd

CY2020

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

123500000

usd

CY2022

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1635800000

usd

CY2021

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1661100000

usd

CY2020

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1582900000

usd

CY2022

us-gaap

Interest Paid Net

InterestPaidNet

120900000

usd

CY2021

us-gaap

Interest Paid Net

InterestPaidNet

92800000

usd

CY2020

us-gaap

Interest Paid Net

InterestPaidNet

111200000

usd

CY2022

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

332200000

usd

CY2021

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

298800000

usd

CY2020

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

275800000

usd

CY2022

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

985700000

usd

CY2021

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

926200000

usd

CY2020

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

818100000

usd

CY2022

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

33900000

usd

CY2021

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

-19800000

usd

CY2020

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

28400000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

495400000

usd

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

598300000

usd

CY2020

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

735500000

usd

CY2022

cno

Sales Of Investments

SalesOfInvestments

3253600000

usd

CY2021

cno

Sales Of Investments

SalesOfInvestments

1823600000

usd

CY2020

cno

Sales Of Investments

SalesOfInvestments

1480000000

usd

CY2022

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

1550700000

usd

CY2021

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

2880300000

usd

CY2020

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

2218300000

usd

CY2022

cno

Purchases Of Investments

PurchasesOfInvestments

6482000000

usd

CY2021

cno

Purchases Of Investments

PurchasesOfInvestments

6135200000

usd

CY2020

cno

Purchases Of Investments

PurchasesOfInvestments

4280700000

usd

CY2022

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

-42400000

usd

CY2021

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

-19500000

usd

CY2020

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

13800000

usd

CY2022

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

61200000

usd

CY2021

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

75300000

usd

CY2020

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

39800000

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-1781300000

usd

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-1526100000

usd

CY2020

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-608400000

usd

CY2022

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

usd

CY2021

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

usd

CY2020

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

145800000

usd

CY2022

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

13500000

usd

CY2021

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

21500000

usd

CY2020

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

19000000.0

usd

CY2022

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

190100000

usd

CY2021

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

407800000

usd

CY2020

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

268300000

usd

CY2022

us-gaap

Payments Of Dividends

PaymentsOfDividends

64800000

usd

CY2021

us-gaap

Payments Of Dividends

PaymentsOfDividends

65700000

usd

CY2020

us-gaap

Payments Of Dividends

PaymentsOfDividends

67000000.0

usd

CY2022

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

3022600000

usd

CY2021

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

2405100000

usd

CY2020

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

1620100000

usd

CY2022

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1461400000

usd

CY2021

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1352500000

usd

CY2020

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1235600000

usd

CY2022

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

285000000.0

usd

CY2021

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

795800000

usd

CY2020

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

498000000.0

usd

CY2022

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

361300000

usd

CY2021

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

722400000

usd

CY2020

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

499800000

usd

CY2022

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

44400000

usd

CY2021

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

5400000

usd

CY2020

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

2100000

usd

CY2022

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

usd

CY2021

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

1000000.0

usd

CY2020

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

1199100000

usd

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

667600000

usd

CY2020

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

210100000

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-86800000

usd

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-260200000

usd

CY2020

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

337200000

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

731700000

usd

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

991900000

usd

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

654700000

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

644900000

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

731700000

usd

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

991900000

usd

CY2022

cno

Discount Rate Used To Determine Present Value Of Future Insurance Profits

DiscountRateUsedToDeterminePresentValueOfFutureInsuranceProfits

0.12

CY2022

us-gaap

Ceded Premiums Written

CededPremiumsWritten

206200000

usd

CY2021

us-gaap

Ceded Premiums Written

CededPremiumsWritten

222400000

usd

CY2020

us-gaap

Ceded Premiums Written

CededPremiumsWritten

239500000

usd

CY2022

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

361400000

usd

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

310900000

usd

CY2020

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

403800000

usd

CY2022

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

18700000

usd

CY2021

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

20300000

usd

CY2020

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

23000000

usd

CY2022

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

25000000

usd

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

24900000

usd

CY2020

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

31400000

usd

CY2022Q4

cno

Investments Held In Limited Partnerships And Hedge Funds

InvestmentsHeldInLimitedPartnershipsAndHedgeFunds

588900000

usd

CY2022Q4

cno

Unfunded Commitmentsto Limited Partnerships

UnfundedCommitmentstoLimitedPartnerships

441200000

usd

CY2022

cno

Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank

NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank

3

subsidiary

CY2022

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

33500000

usd

CY2021

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

9800000

usd

CY2020

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

21200000

usd

CY2022

us-gaap

Derivatives Methods Of Accounting Nonhedging Derivatives

DerivativesMethodsOfAccountingNonhedgingDerivatives

<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed indexed annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. We are generally able to change the participation rate at the beginning of each index period (typically on each policy anniversary date), subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed indexed annuity products at estimated fair value. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivative is based on the estimated cost to fulfill our commitment to fixed indexed annuity policyholders to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. In valuing these options, we are required to make assumptions regarding: (i) future index values to determine both the future notional amounts at each anniversary date and the future prices of the forward starting options; (ii) future annual participation rates; and (iii) non-economic factors related to policy persistency. These assumptions are used to estimate the future cost to purchase the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and risk margins for non-capital market inputs. The non-performance risk adjustment is determined by taking into consideration publicly available information related to spreads in the secondary market for debt with credit ratings similar to ours. These observable spreads are then adjusted to reflect the priority of these liabilities and the claim paying ability of the issuing insurance subsidiaries.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk margins are established to capture non-capital market risks which represent the additional compensation a market participant would require to assume the risks related to the uncertainties regarding the embedded derivatives, including future policyholder behavior related to persistency. The determination of the risk margin is highly judgmental given the lack of a market to assume the risks solely related to the embedded derivatives of our fixed indexed annuity products.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the appropriate risk-free rate and non-performance risk is sensitive to the economic and interest rate environment. Accordingly, the value of the derivative is volatile due to external market sensitivities, which may materially affect net income. Additionally, changes in the judgmental assumptions regarding the appropriate risk margin can significantly impact the value of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.</span></div>

CY2022

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

22500000

usd

CY2021

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

17300000

usd

CY2020

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

14100000

usd

CY2022

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

17800000

usd

CY2021

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

15500000

usd

CY2020

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

15400000

usd

CY2022Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

65900000

usd

CY2021Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

61200000

usd

CY2020Q1

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

21293100000

usd

CY2020Q1

us-gaap

Notes Receivable Net

NotesReceivableNet

1559400000

usd

CY2020Q1

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1178700000

usd

CY2020Q1

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

437500000

usd

CY2020Q1

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4781700000

usd

CY2020Q1

us-gaap

Assets

33613100000

usd

CY2020Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

517900000

usd

CY2020Q1

us-gaap

Stockholders Equity

StockholdersEquity

4659200000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss

23384200000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

20353400000

usd

CY2022Q4

cno

Available For Sale Securities Fair Value Disclosure Percentage Of Estimated Fair Value

AvailableForSaleSecuritiesFairValueDisclosurePercentageOfEstimatedFairValue

1.000

CY2022Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses

-1247000000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses

2963300000

usd

CY2022Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses

-1780700000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses

-23100000

usd

CY2022Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits

AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits

8200000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits

AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits

-8300000

usd

CY2022Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs

AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts

331700000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs

AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts

-420200000

usd

CY2022Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

0

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-25500000

usd

CY2022Q4

cno

Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities

AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities

594700000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities

AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities

-539100000

usd

CY2022Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-2093100000

usd

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1947100000

usd

CY2021Q4

cno

Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-7300000

usd

CY2021Q4

cno

Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-132200000

usd

CY2021Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-25500000

usd

CY2021Q4

cno

Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

35800000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

112000000.0

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

110800000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

1913700000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

1790200000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost

2098900000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue

1910400000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost

12629400000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue

10523200000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities

16754000000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities

AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities

14334600000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost

6630200000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue

6018800000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss

23384200000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

20353400000

usd

CY2022

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

1084100000

usd

CY2021

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

962600000

usd

CY2020

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

924800000

usd

CY2022

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

5900000

usd

CY2021

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

4300000

usd

CY2020

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

3000000.0

usd

CY2022

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

63000000.0

usd

CY2021

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

65000000.0

usd

CY2020

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

79500000

usd

CY2022

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8400000

usd

CY2021

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8200000

usd

CY2020

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8500000

usd

CY2022

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

38000000.0

usd

CY2021

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

124800000

usd

CY2020

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

84000000.0

usd

CY2022

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

5900000

usd

CY2021

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

300000

usd

CY2020

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

2600000

usd

CY2022

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

7700000

usd

CY2021

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

7200000

usd

CY2020

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

28100000

usd

CY2022

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

-6300000

usd

CY2021

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

212000000.0

usd

CY2020

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

35000000.0

usd

CY2022

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

-200300000

usd

CY2021

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

8900000

usd

CY2020

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

4500000

usd

CY2022

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

35800000

usd

CY2021

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

52400000

usd

CY2020

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

75900000

usd

CY2022

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1042200000

usd

CY2021

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1445700000

usd

CY2020

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1245900000

usd

CY2022

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

26300000

usd

CY2021

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

25000000.0

usd

CY2020

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

23400000

usd

CY2022

us-gaap

Net Investment Income

NetInvestmentIncome

1015900000

usd

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

1420700000

usd

CY2020

us-gaap

Net Investment Income

NetInvestmentIncome

1222500000

usd

CY2022Q4

cno

Carrying Value Of Fixed Maturity Investments Not Accruing Investment Income

CarryingValueOfFixedMaturityInvestmentsNotAccruingInvestmentIncome

1000000

usd

CY2022Q4

cno

Carrying Value Mortgage Loans Not Accruing Investment Income

CarryingValueMortgageLoansNotAccruingInvestmentIncome

0

usd

CY2022

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-17900000

usd

CY2021

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

21300000

usd

CY2020

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-18400000

usd

CY2022

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

52600000

usd

CY2021

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

-12200000

usd

CY2020

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

18500000

usd

CY2022

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

-2900000

usd

CY2021

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

-7300000

usd

CY2020

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

-1800000

usd

CY2022

cno

Increase Decrease In Fair Value Of Other Securities

IncreaseDecreaseInFairValueOfOtherSecurities

-62000000.0

usd

CY2021

cno

Increase Decrease In Fair Value Of Other Securities

IncreaseDecreaseInFairValueOfOtherSecurities

-7100000

usd

CY2020

cno

Increase Decrease In Fair Value Of Other Securities

IncreaseDecreaseInFairValueOfOtherSecurities

2500000

usd

CY2022

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-117500000

usd

CY2021

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-2200000

usd

CY2020

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-17800000

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-135400000

usd

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

usd

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

usd

CY2022

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

-1800000

usd

CY2021

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

11400000

usd

CY2020

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

-5200000

usd

CY2022

cno

Increase Decrease In Equity Securities Fvni Held At End Of Period

IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod

-7300000

usd

CY2021

cno

Increase Decrease In Equity Securities Fvni Held At End Of Period

IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod

-7800000

usd

CY2020

cno

Increase Decrease In Equity Securities Fvni Held At End Of Period

IncreaseDecreaseInEquitySecuritiesFVNIHeldAtEndOfPeriod

-1700000

usd

CY2022

us-gaap

Increase Decrease In Debt Securities Trading

IncreaseDecreaseInDebtSecuritiesTrading

-43300000

usd

CY2021

us-gaap

Increase Decrease In Debt Securities Trading

IncreaseDecreaseInDebtSecuritiesTrading

-3100000

usd

CY2020

us-gaap

Increase Decrease In Debt Securities Trading

IncreaseDecreaseInDebtSecuritiesTrading

400000

usd

CY2022

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-135400000

usd

CY2022

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

52600000

usd

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

usd

CY2021

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

-12200000

usd

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

usd

CY2020

cno

Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease

DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease

18500000

usd

CY2022Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2022

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

1651500000

usd

CY2021

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

493500000

usd

CY2020

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

507100000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Within One Year Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBasisWithUnrealizedLosses

91200000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Within One Year Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueWithUnrealizedLosses

89800000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBasisWithUnrealizedLosses

1741900000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueWithUnrealizedLosses

1615500000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBasisWithUnrealizedLosses

1845300000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueWithUnrealizedLosses

1649800000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBasisWithUnrealizedLosses

11631200000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities After Ten Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueWithUnrealizedLosses

9485800000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost With Unrealized Losses Subtotal

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostWithUnrealizedLossesSubtotal

15309600000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Subtotal

AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesSubtotal

12840900000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBasisWithUnrealizedLosses

6040100000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueWithUnrealizedLosses

5385900000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost Basis With Unrealized Losses Total

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisWithUnrealizedLossesTotal

21349700000

usd

CY2022Q4

cno

Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Total

AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesTotal

18226800000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

7636900000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

835200000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

1897500000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

471600000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position

DebtSecuritiesAvailableForSaleUnrealizedLossPosition

9534400000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

1306800000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

1698600000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

15100000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

122200000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

3400000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position

DebtSecuritiesAvailableForSaleUnrealizedLossPosition

1820800000

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

18500000

usd

CY2019Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

2100000

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded

25700000

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase

DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal

-24100000

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Securities Sold

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold

1500000

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery

0

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Writeoff

DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff

0

usd

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery

0

usd

CY2020Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

2200000

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded

6300000

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase

DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal

0

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Securities Sold

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold

900000

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery

0

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Writeoff

DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff

0

usd

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery

0

usd

CY2021Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

7600000

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded

50400000

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase

DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal

10300000

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Securities Sold

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold

12300000

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery

0

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Writeoff

DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff

0

usd

CY2022

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery

0

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

56000000.0

usd

CY2022Q4

cno

Available For Sale Securities Structured Securities Fair Value

AvailableForSaleSecuritiesStructuredSecuritiesFairValue

6000000000

usd

CY2022Q4

cno

Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities

AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities

0.296

CY2022Q4

cno

Available For Sale Securities Structured Securities Amortized Cost Basis

AvailableForSaleSecuritiesStructuredSecuritiesAmortizedCostBasis

6630200000

usd

CY2022Q4

cno

Available For Sale Securities Structured Securities Fair Value

AvailableForSaleSecuritiesStructuredSecuritiesFairValue

6018800000

usd

CY2022Q4

cno

Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities

AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities

0.296

CY2022Q4

cno

Number Of Additional States Greater Than Specified Percentage Of Mortgage Loan Balance

NumberOfAdditionalStatesGreaterThanSpecifiedPercentageOfMortgageLoanBalance

0

state

CY2019Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

6700000

usd

CY2020

us-gaap

Provision For Loan Losses Expensed

ProvisionForLoanLossesExpensed

-5100000

usd

CY2020

us-gaap

Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase

FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2020

us-gaap

Financing Receivable Allowance For Credit Losses Write Offs

FinancingReceivableAllowanceForCreditLossesWriteOffs

0

usd

CY2020

us-gaap

Financing Receivable Allowance For Credit Losses Recovery

FinancingReceivableAllowanceForCreditLossesRecovery

0

usd

CY2020Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

11800000

usd

CY2021

us-gaap

Provision For Loan Losses Expensed

ProvisionForLoanLossesExpensed

6200000

usd

CY2021

us-gaap

Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase

FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2021

us-gaap

Financing Receivable Allowance For Credit Losses Write Offs

FinancingReceivableAllowanceForCreditLossesWriteOffs

0

usd

CY2021

us-gaap

Financing Receivable Allowance For Credit Losses Recovery

FinancingReceivableAllowanceForCreditLossesRecovery

0

usd

CY2021Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

5600000

usd

CY2022

us-gaap

Provision For Loan Losses Expensed

ProvisionForLoanLossesExpensed

-2400000

usd

CY2022

us-gaap

Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase

FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

usd

CY2022

us-gaap

Financing Receivable Allowance For Credit Losses Write Offs

FinancingReceivableAllowanceForCreditLossesWriteOffs

0

usd

CY2022

us-gaap

Financing Receivable Allowance For Credit Losses Recovery

FinancingReceivableAllowanceForCreditLossesRecovery

0

usd

CY2022Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

8000000.0

usd

CY2022Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

37200000

usd

CY2021Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

38800000

usd

CY2022Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2021Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2022

cno

Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage

FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage

0.89

CY2022Q4

cno

Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent

AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent

0.86

CY2022Q4

cno

Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent

AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent

0.49

CY2022Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11809100000

usd

CY2021Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11670700000

usd

CY2022Q4

us-gaap

Policyholder Contract Deposits

PolicyholderContractDeposits

14858300000

usd

CY2021Q4

us-gaap

Policyholder Contract Deposits

PolicyholderContractDeposits

13689700000

usd

CY2022

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:58.086%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance (receivables) payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(814.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred claims related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on claim reserves</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid claims related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(802.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,144.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add reinsurance receivables (payables)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.</span></div>

CY2022

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

31800000

usd

CY2021

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

64100000

usd

CY2020

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

-24000000.0

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

88700000

usd

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

62600000

usd

CY2020

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

100500000

usd

CY2022

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

120500000

usd

CY2021

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

126700000

usd

CY2020

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

76500000

usd

CY2022

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

0

usd

CY2021

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

0

usd

CY2020

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

-34000000.0

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

120500000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

126700000

usd

CY2020

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

42500000

usd

CY2020

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

-34000000

usd

CY2021Q3

cno

Tax Refund Due To Cares Act

TaxRefundDueToCARESAct

80000000

usd

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2021

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2020

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.004

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.005

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.004

CY2022Q4

cno

Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets

DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets

214800000

usd

CY2022

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.027

CY2021

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.018

CY2020

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.016

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.099

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.233

CY2021

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.223

CY2020

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.123

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

166000000.0

usd

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

241400000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2500000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2300000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

322200000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

390700000

usd

CY2021Q4

cno

Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets

DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets

158300000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Other Comprehensive Loss

DeferredTaxAssetsOtherComprehensiveLoss

589000000.0

usd

CY2021Q4

us-gaap

Deferred Tax Assets Other Comprehensive Loss

DeferredTaxAssetsOtherComprehensiveLoss

0

usd

CY2022Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

7300000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

27500000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

1301800000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

820200000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

37200000

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

48200000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

107100000

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

119400000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

0

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

540400000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

144300000

usd

CY2021Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

708000000.0

usd

CY2022Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

1157500000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

112200000

usd

CY2022Q4

cno

Prepaid Accrued Income Taxes Current

PrepaidAccruedIncomeTaxesCurrent

8000000.0

usd

CY2021Q4

cno

Prepaid Accrued Income Taxes Current

PrepaidAccruedIncomeTaxesCurrent

6100000

usd

CY2022Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

1165500000

usd

CY2021Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

118300000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

1157500000

usd

CY2022Q4

cno

Loss Limitation Based On Income Of Life Insurance Company

LossLimitationBasedOnIncomeOfLifeInsuranceCompany

0.35

CY2022Q4

cno

Loss Limitation Based On Loss Of Non Life Entities

LossLimitationBasedOnLossOfNonLifeEntities

0.35

CY2022Q4

cno

Federal Long Term Tax Exempt Rate

FederalLongTermTaxExemptRate

0.0329

CY2022Q4

cno

Ownership Change Threshold Restricting Net Operating Loss Usage

OwnershipChangeThresholdRestrictingNetOperatingLossUsage

0.50

CY2009Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.05

CY2009Q1

cno

Operating Loss Carryforward Limitation Numberof Rightsfor Each Share

OperatingLossCarryforwardLimitationNumberofRightsforEachShare

1

right

CY2009Q1

cno

Ownership Percentage Threshold Relating To Company382 Securities

OwnershipPercentageThresholdRelatingToCompany382Securities

0.0499

CY2009Q1

cno

Ownership Percentage Threshold Relating To Company382 Securities

OwnershipPercentageThresholdRelatingToCompany382Securities

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2022Q4

cno

Nonoperating Loss Carryforwards

NonoperatingLossCarryforwards

790300000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2500000

usd

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2300000

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

usd

CY2021Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

usd

CY2022Q4

us-gaap

Deferred Finance Costs Noncurrent Gross

DeferredFinanceCostsNoncurrentGross

11200000

usd

CY2021Q4

us-gaap

Deferred Finance Costs Noncurrent Gross

DeferredFinanceCostsNoncurrentGross

12700000

usd

CY2022Q4

us-gaap

Notes Payable

NotesPayable

1138800000

usd

CY2021Q4

us-gaap

Notes Payable

NotesPayable

1137300000

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

0

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

0

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

500000000.0

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

0

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

0

usd

CY2022Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal After Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

650000000.0

usd

CY2022Q4

us-gaap

Debt Instrument Carrying Amount

DebtInstrumentCarryingAmount

1150000000

usd

CY2022

us-gaap

Loss Contingency Disclosures

LossContingencyDisclosures

LITIGATION AND OTHER LEGAL PROCEEDINGS<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 9, 2019, Bankers Conseco Life Insurance Company ("BCLIC") and Washington National commenced an action entitled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with Beechwood Re Ltd. ("BRe"), as well as for breaching its fiduciary duties to BCLIC and Washington National. The Court granted Wilmington's motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On April 20, 2021, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated breach of contract and breach of fiduciary duty claims against Wilmington. The Wilmington Action is currently pending in the Supreme Court of the State of New York, County of New York, Commercial Division.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, CNO Financial Group, Inc., BCLIC, Washington National and 40|86 Advisors, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court. Plaintiffs seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities were fraudulently transferred to the reinsurance trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties are vigorously contesting the plaintiff's claims. The CNO Parties had removed the case to the United States District Court for the District of Delaware but on April 6, 2020, the District Court granted the plaintiff's motion to remand the case back to the Delaware Chancery Court. Plaintiffs have filed an Amended Complaint and the CNO Parties have moved to dismiss the Amended Complaint. The Delaware Chancery Court denied the CNO Parties’ motions to dismiss the Amended Complaint on the basis of forum non conveniens, but granted the CNO Parties’ motion to stay the case pending the conclusion of a related matter. After the stay is lifted, the court will address the CNO Parties’ and other defendants’ motions to dismiss the Amended Complaint on numerous other grounds.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 28, 2019, BCLIC and Washington National commenced an action entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe. The Court granted KPMG’s motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On December 1, 2020, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated the aiding and abetting claim against KPMG. The KPMG Action is currently pending in the Supreme Court of the State of New York, County of New York, Commercial Division.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 5, 2012, plaintiffs William Jeffrey Burnett and Joe H. Camp commenced an action entitled Burnett v. Conseco Life Ins. Co. against, among others, CNO Financial Group, Inc. and CNO Services, LLC (collectively, the "CNO Entities") in the United States District Court for the Central District of California on behalf of a putative class of former interest-sensitive whole life insurance policyholders who surrendered their policies or let them lapse. Plaintiffs' First Amended Complaint alleges that the CNO Entities are liable under an alter ego theory for Conseco Life Insurance Company's purported breach of the Optional Premium Payment Provision of plaintiffs' insurance policies. In January 2018, the case was transferred to the Southern District of Indiana. On August 17, 2020, the Court denied the CNO Entities' motions to dismiss. On January 13, 2021, the Court granted final approval of a class action settlement between plaintiffs and co-defendant Conseco Life Insurance Company (n/k/a Wilco Life Insurance Company). The case remains pending against the CNO Entities. On March 25, 2022, the Court certified a Rule 23(b)(3) class of under 2,000 policyholders who invoked the policy's Optional Premium Payment prior to October 2008 and who surrendered between October 7, 2008 and September 1, 2011. The Court's certification order acknowledged the existence of individualized issues of causation and damages, which the court stated could be addressed in individualized proceedings following a class trial on the alter ego allegations and the meaning of the subject insurance policy language. The CNO Entities continue to vigorously defend the case.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Examinations and Fines</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We provided information to the examiners in response to their requests. A total of 42 states and the District of Columbia participated in this examination. In November 2018, we entered into an agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds (the "Global Resolution Agreement"). Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions compared expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made. In May 2022, we received written notification that the exam is closed.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty Fund Assessments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet at December 31, 2022, included: (i) accruals of $6.2 million, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through December 31, 2022; and (ii) receivables of $10.6 million that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At December 31, 2021, such guaranty fund assessment accruals were $6.8 million and such receivables were $12.6 million. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of $2.1 million, $2.7 million and $2.9 million in 2022, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of the employment agreements of two of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was $20.5 million and $21.2 million at December 31, 2022 and 2021, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Certain Other Long-Term Commitments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents office space, equipment and computer software under contractual commitments or noncancellable operating lease agreements. Total expense pursuant to these agreements was $86.4 million, $76.3 million and $74.9 million in 2022, 2021 and 2020, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents office space for certain administrative operations under an agreement that expires in 2023. We lease sales offices in various states which are generally short-term in length with remaining lease terms expiring between 2023 and 2028. Many leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term only if the Company is reasonably certain of exercising those options. In determining the present value of lease payments, the Company uses its incremental borrowing rate for borrowings secured by collateral commensurate with the terms of the underlying lease. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to our right of use assets are as follows (dollars in millions):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:67.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for lease liabilities (non-cash transactions)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE1Mjk1ZDFhMTRhZDRkMTY4NGU5MWFlMDU2ZjRmZDVjL3NlYzphNTI5NWQxYTE0YWQ0ZDE2ODRlOTFhZTA1NmY0ZmQ1Y18yMDUvZnJhZzozNzYxZGY2YmExMjg0YWQ4YTIwYzM1YmNmOTc5NDhmZi90YWJsZTphNGNiZWIzZDAyYjA0MGZkYTdlZmJhNDU5NjViNDRjOC90YWJsZXJhbmdlOmE0Y2JlYjNkMDJiMDQwZmRhN2VmYmE0NTk2NWI0NGM4XzUtMC0xLTEtOTc3MDc_2da51dba-23f6-43f3-b3c4-30c6fb201e0e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE1Mjk1ZDFhMTRhZDRkMTY4NGU5MWFlMDU2ZjRmZDVjL3NlYzphNTI5NWQxYTE0YWQ0ZDE2ODRlOTFhZTA1NmY0ZmQ1Y18yMDUvZnJhZzozNzYxZGY2YmExMjg0YWQ4YTIwYzM1YmNmOTc5NDhmZi90YWJsZTphNGNiZWIzZDAyYjA0MGZkYTdlZmJhNDU5NjViNDRjOC90YWJsZXJhbmdlOmE0Y2JlYjNkMDJiMDQwZmRhN2VmYmE0NTk2NWI0NGM4XzUtMC0xLTEtOTc3MDc_a83cd604-724d-490d-80ef-db58ce304cfa">Total right of use assets</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of our operating lease liabilities as of December 31, 2022 are as follows (dollars in millions):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.403%"><tr><td style="width:1.0%"/><td style="width:77.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE1Mjk1ZDFhMTRhZDRkMTY4NGU5MWFlMDU2ZjRmZDVjL3NlYzphNTI5NWQxYTE0YWQ0ZDE2ODRlOTFhZTA1NmY0ZmQ1Y18yMDUvZnJhZzozNzYxZGY2YmExMjg0YWQ4YTIwYzM1YmNmOTc5NDhmZi90YWJsZTpiYzgwODA1MjgwMWQ0MmM2YWVhMGRhZjdjYTM5MjQ4ZC90YWJsZXJhbmdlOmJjODA4MDUyODAxZDQyYzZhZWEwZGFmN2NhMzkyNDhkXzgtMC0xLTEtOTc3MDc_931a0996-972e-46b1-a729-a009a1c7c5e3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE1Mjk1ZDFhMTRhZDRkMTY4NGU5MWFlMDU2ZjRmZDVjL3NlYzphNTI5NWQxYTE0YWQ0ZDE2ODRlOTFhZTA1NmY0ZmQ1Y18yMDUvZnJhZzozNzYxZGY2YmExMjg0YWQ4YTIwYzM1YmNmOTc5NDhmZi90YWJsZTpiYzgwODA1MjgwMWQ0MmM2YWVhMGRhZjdjYTM5MjQ4ZC90YWJsZXJhbmdlOmJjODA4MDUyODAxZDQyYzZhZWEwZGFmN2NhMzkyNDhkXzgtMC0xLTEtOTc3MDc_9dfc2cd8-e3fe-4337-a037-ebe36f26a5dd">Present value of lease liabilities</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.403%"><tr><td style="width:1.0%"/><td style="width:77.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>

CY2019Q2

cno

Number Of Trust Agreements

NumberOfTrustAgreements

4

trust_agreement

CY2022Q1

cno

Number Of Policyholders

NumberOfPolicyholders

2000

policyholder

cno

Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws

NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws

42

state

CY2022

us-gaap

Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability

LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability

6200000

usd

CY2022Q4

us-gaap

Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset

LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset

10600000

usd

CY2021

us-gaap

Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability

LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability

6800000

usd

CY2021Q4

us-gaap

Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset

LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset

12600000

usd

CY2022

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2100000

usd

CY2021

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2700000

usd

CY2020

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2900000

usd

CY2022

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

86400000

usd

CY2021

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

76300000

usd

CY2020

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

74900000

usd

CY2022

us-gaap

Operating Lease Cost

OperatingLeaseCost

24300000

usd

CY2021

us-gaap

Operating Lease Cost

OperatingLeaseCost

24600000

usd

CY2022

us-gaap

Operating Lease Payments

OperatingLeasePayments

25500000

usd

CY2021

us-gaap

Operating Lease Payments

OperatingLeasePayments

25700000

usd

CY2022

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

21700000

usd

CY2021

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

17300000

usd

CY2022Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

46600000

usd

CY2021Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

48200000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

22400000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

13500000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

8100000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

4800000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

1900000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due After Year Five

LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

600000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

51300000

usd

CY2022Q4

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

1700000

usd

CY2022Q4

us-gaap

Operating Lease Liability

OperatingLeaseLiability

49600000

usd

CY2022Q4

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P3Y

CY2022Q4

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.0230

CY2022

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

10300000

usd

CY2021

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

6700000

usd

CY2020

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

6000000

usd

CY2022Q4

cno

Stock Repurchase Program Remaining Repurchase Authorized Amount

StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount

186900000

usd

CY2022

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

-222700000

usd

CY2021

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

217800000

usd

CY2020

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

42100000

usd

CY2022

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

7600000

shares

CY2021

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

16600000

shares

CY2020

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

14500000

shares

CY2022

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

180000000

usd

CY2021

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

402400000

usd

CY2020

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

263000000

usd

CY2022Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

65000000

usd

CY2022

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.55

CY2021Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

66100000

usd

CY2021

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.51

CY2020Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

67400000

usd

CY2020

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.47

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.14

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.13

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.13

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.12

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.12

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.11

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

5600000

shares

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

7800000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

8800000

shares

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

3411000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.01

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.28

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2022

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

0

CY2022

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

618000

shares

CY2022

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

18.43

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

3800000

usd

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

57000

shares

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

20.18

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

2736000

shares

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.45

CY2022

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P4Y8M12D

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

15100000

usd

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

2540000

shares

CY2022

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y7M6D

CY2022Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

14100000

usd

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

4544000

shares

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

0

CY2021

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

1023000

shares

CY2021

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

18.01

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

7800000

usd

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

110000

shares

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

19.97

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

3411000

shares

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.28

CY2021

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

19200000

usd

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

2662000

shares

CY2021

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y7M6D

CY2021Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

15700000

usd

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

6015000

shares

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

18.59

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2020

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

0

CY2020

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

1104000

shares

CY2020

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

16.59

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

9000000.0

usd

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

367000

shares

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

19.40

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

4544000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.01

CY2020

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y7M6D

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

27500000

usd

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

2946000

shares

CY2020

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y6M

CY2020Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

19900000

usd

CY2022

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

10400000

usd

CY2021

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

18400000

usd

CY2020

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

16500000

usd

CY2022Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

2736000

shares

CY2022Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

2540000

shares

CY2009Q1

cno

Operating Loss Carryforward Limitation Numberof Rightsfor Each Share

OperatingLossCarryforwardLimitationNumberofRightsforEachShare

1

right

CY2022Q4

cno

Price Per One Thousandthof A Shareof Junior Preferred Stock

PricePerOneThousandthofAShareofJuniorPreferredStock

95.00

CY2022

cno

Preferred Stock Purchase Right Rights Would Become Exercisableinthe Eventany Personor Group Becomes Ownerofa Stated Percentage Percentage

PreferredStockPurchaseRightRightsWouldBecomeExercisableintheEventanyPersonorGroupBecomesOwnerofaStatedPercentagePercentage

0.0499

CY2022

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

396800000

usd

CY2021

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

441000000.0

usd

CY2020

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

301800000

usd

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

115733000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

128400000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

142096000

shares

CY2022

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1984000

shares

CY2021

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2726000

shares

CY2020

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1068000

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

117717000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

131126000

shares

CY2020

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

143164000

shares

CY2022

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4619700000

usd

CY2021

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4457700000

usd

CY2020

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4176000000

usd

CY2022

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

18600000

usd

CY2021

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

20700000

usd

CY2020

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

23000000.0

usd

CY2022

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

214600000

usd

CY2021

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

231300000

usd

CY2020

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

247800000

usd

CY2022

us-gaap

Premiums Written Net

PremiumsWrittenNet

4423700000

usd

CY2021

us-gaap

Premiums Written Net

PremiumsWrittenNet

4247100000

usd

CY2020

us-gaap

Premiums Written Net

PremiumsWrittenNet

3951200000

usd

CY2022

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-9800000

usd

CY2021

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-900000

usd

CY2020

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-9200000

usd

CY2022

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

2123600000

usd

CY2021

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

1905200000

usd

CY2020

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

1620100000

usd

CY2022

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2309900000

usd

CY2021

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2342800000

usd

CY2020

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2340300000

usd

CY2022

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

189900000

usd

CY2021

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

180600000

usd

CY2020

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

171000000.0

usd

CY2022

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2499800000

usd

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2523400000

usd

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2511300000

usd

CY2022Q4

us-gaap

Number Of States In Which Entity Operates

NumberOfStatesInWhichEntityOperates

4

state

CY2022

cno

Specified Percentage Of Total Collected Premiums That State Must Exceed To Be Identified

SpecifiedPercentageOfTotalCollectedPremiumsThatStateMustExceedToBeIdentified

0.05

CY2022

us-gaap

Insurance Commissions

InsuranceCommissions

117900000

usd

CY2021

us-gaap

Insurance Commissions

InsuranceCommissions

116400000

usd

CY2020

us-gaap

Insurance Commissions

InsuranceCommissions

111800000

usd

CY2022

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

287900000

usd

CY2021

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

267900000

usd

CY2020

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

252600000

usd

CY2022

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

548800000

usd

CY2021

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

603000000.0

usd

CY2020

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

577600000

usd

CY2022

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

954600000

usd

CY2021

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

987300000

usd

CY2020

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

942000000.0

usd

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1112000000

usd

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1027800000

usd

CY2019Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1215500000

usd

CY2022

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

332200000

usd

CY2021

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

298800000

usd

CY2020

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

275800000

usd

CY2022

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

282700000

usd

CY2021

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

252400000

usd

CY2020

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

233400000

usd

CY2022

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

751900000

usd

CY2021

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

37800000

usd

CY2020

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

-230100000

usd

CY2022Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1913400000

usd

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1112000000

usd

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1027800000

usd

CY2021Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

222600000

usd

CY2020Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

249400000

usd

CY2019Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

275400000

usd

CY2022

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

26900000

usd

CY2021

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

28700000

usd

CY2020

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

34700000

usd

CY2022

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

16500000

usd

CY2021

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

1900000

usd

CY2020

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

8700000

usd

CY2022Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

212200000

usd

CY2021Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

222600000

usd

CY2020Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

249400000

usd

CY2022Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year One

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearOne

0.11

CY2022Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Two

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearTwo

0.11

CY2022Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Three

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearThree

0.09

CY2022Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Four

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFour

0.08

CY2022Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Five

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFive

0.07

CY2022

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2021

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2020

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

396800000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

usd

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

345300000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

319500000

usd

CY2020

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

303900000

usd

CY2022

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

86600000

usd

CY2021

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

146500000

usd

CY2020

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

14100000

usd

CY2022

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

-175600000

usd

CY2021

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

346200000

usd

CY2020

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

397600000

usd

CY2022

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

138700000

usd

CY2021

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

-347600000

usd

CY2020

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

-125200000

usd

CY2022

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

332200000

usd

CY2021

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

298800000

usd

CY2020

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

275800000

usd

CY2022

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

-135400000

usd

CY2021

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

19100000

usd

CY2020

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

-36200000

usd

CY2022

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

-99600000

usd

CY2021

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

10600000

usd

CY2020

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

82900000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

495400000

usd

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

598300000

usd

CY2020

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

735500000

usd

CY2022

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

25200000

usd

CY2021

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

26000000.0

usd

CY2020

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

24500000

usd

CY2022Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

1849800000

usd

CY2021Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

1799600000

usd

CY2022Q4

cno

Statutory Accounting Practices Statutory Asset Valuation Reserve

StatutoryAccountingPracticesStatutoryAssetValuationReserve

305800000

usd

CY2021Q4

cno

Statutory Accounting Practices Statutory Asset Valuation Reserve

StatutoryAccountingPracticesStatutoryAssetValuationReserve

332500000

usd

CY2022Q4

cno

Statutory Accounting Practices Statutory Interest Maintenance Reserve

StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve

395700000

usd

CY2021Q4

cno

Statutory Accounting Practices Statutory Interest Maintenance Reserve

StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve

407900000

usd

CY2022Q4

cno

Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total

StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal

2551300000

usd

CY2021Q4

cno

Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total

StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal

2540000000

usd

CY2021Q4

cno

Investments In Upstream Affiliates Included In Statutory Capital And Surplus

InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus

42600000

usd

CY2022Q4

cno

Investments In Upstream Affiliates Included In Statutory Capital And Surplus

InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus

42600000

usd

CY2022

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

238000000

usd

CY2021

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

277500000

usd

CY2020

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

409600000

usd

CY2020

cno

Statutory Accounting Practices Net Operating Income Cares Act

StatutoryAccountingPracticesNetOperatingIncomeCARESAct

99000000

usd

CY2020

cno

Statutory Accounting Practices Capital And Surplus Cares Act

StatutoryAccountingPracticesCapitalAndSurplusCARESAct

53000000

usd

CY2022

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-25900000

usd

CY2021

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-11200000

usd

CY2020

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-11900000

usd

CY2022

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

168400000

usd

CY2021

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

164200000

usd

CY2020

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

163800000

usd

CY2022Q4

cno

Percentage Of Statutory Capital And Surplus Available For Dividend Distribution Without Prior Approval From Regulatory Agency

PercentageOfStatutoryCapitalAndSurplusAvailableForDividendDistributionWithoutPriorApprovalFromRegulatoryAgency

0.10

CY2022

cno

Amountof Dividends Paid By Insurance Subsidiaries

AmountofDividendsPaidByInsuranceSubsidiaries

143600000

usd

CY2022

cno

Capital Contribution

CapitalContribution

14600000

usd

CY2022Q4

cno

Trended Adjusted Capitalto Riskbased Capital Ratio Threshold

TrendedAdjustedCapitaltoRiskbasedCapitalRatioThreshold

0.95

CY2022

cno

Numberof Product Lines

NumberofProductLines

3

product_line

CY2022

cno

Numberof Product Lines

NumberofProductLines

3

product_line

CY2022

cno

Segment Revenues

SegmentRevenues

3667000000

usd

CY2021

cno

Segment Revenues

SegmentRevenues

4076100000

usd

CY2020

cno

Segment Revenues

SegmentRevenues

3807500000

usd

CY2022

cno

Interest Credited

InterestCredited

usd

CY2022

cno

Segment Expenses

SegmentExpenses

3309900000

usd

CY2021

cno

Segment Expenses

SegmentExpenses

3605500000

usd

CY2020

cno

Segment Expenses

SegmentExpenses

3343700000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

357100000

usd

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

470600000

usd

CY2020

us-gaap

Operating Income Loss

OperatingIncomeLoss

463800000

usd

CY2022

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

83200000

usd

CY2021

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

105000000.0

usd

CY2020

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

101500000

usd

CY2022

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

273900000

usd

CY2021

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

365600000

usd

CY2020

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

362300000

usd

CY2022

us-gaap

Revenues

3576800000

usd

CY2021

us-gaap

Revenues

4122200000

usd

CY2020

us-gaap

Revenues

3821100000

usd

CY2022

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3059500000

usd

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3554500000

usd

CY2020

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3476800000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

517300000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

567700000

usd

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

344300000

usd

CY2022

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

120500000

usd

CY2021

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

126700000

usd

CY2020

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

76500000

usd

CY2022

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

usd

CY2021

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

usd

CY2020

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-34000000.0

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

396800000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

usd

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

usd

CY2022Q4

us-gaap

Assets

33339200000

usd

CY2021Q4

us-gaap

Assets

36204400000

usd

CY2022Q4

us-gaap

Liabilities

31938400000

usd

CY2021Q4

us-gaap

Liabilities

30944700000

usd

CY2022Q1

us-gaap

Revenues

842900000

usd

CY2022Q2

us-gaap

Revenues

855000000.0

usd

CY2022Q3

us-gaap

Revenues

905300000

usd

CY2022Q4

us-gaap

Revenues

973600000

usd

CY2022Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

149300000

usd

CY2022Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

175400000

usd

CY2022Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

137200000

usd

CY2022Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

55400000

usd

CY2022Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

37000000.0

usd

CY2022Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

39300000

usd

CY2022Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

32200000

usd

CY2022Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

12000000.0

usd

CY2022Q1

us-gaap

Net Income Loss

NetIncomeLoss

112300000

usd

CY2022Q2

us-gaap

Net Income Loss

NetIncomeLoss

136100000

usd

CY2022Q3

us-gaap

Net Income Loss

NetIncomeLoss

105000000.0

usd

CY2022Q4

us-gaap

Net Income Loss

NetIncomeLoss

43400000

usd

CY2022Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.95

CY2022Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.18

CY2022Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.92

CY2022Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.38

CY2022Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.93

CY2022Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.16

CY2022Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.91

CY2022Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.37

CY2021Q1

us-gaap

Revenues

1006000000

usd

CY2021Q2

us-gaap

Revenues

1073100000

usd

CY2021Q3

us-gaap

Revenues

968300000

usd

CY2021Q4

us-gaap

Revenues

1074800000

usd

CY2021Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

190000000.0

usd

CY2021Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

101600000

usd

CY2021Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

128000000.0

usd

CY2021Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

148100000

usd

CY2021Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

42600000

usd

CY2021Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

23600000

usd

CY2021Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

28200000

usd

CY2021Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

32300000

usd

CY2021Q1

us-gaap

Net Income Loss

NetIncomeLoss

147400000

usd

CY2021Q2

us-gaap

Net Income Loss

NetIncomeLoss

78000000.0

usd

CY2021Q3

us-gaap

Net Income Loss

NetIncomeLoss

99800000

usd

CY2021Q4

us-gaap

Net Income Loss

NetIncomeLoss

115800000

usd

CY2021Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.10

CY2021Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.59

CY2021Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.79

CY2021Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.95

CY2021Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.08

CY2021Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.58

CY2021Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.77

CY2021Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.93

CY2022Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2023

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2023

187000000

usd

CY2022Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2024

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2024

266800000

usd

CY2022Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2025

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2025

245400000

usd

CY2022Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2026

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2026

169800000

usd

CY2022Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2027

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2027

100400000

usd

CY2022Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2028

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2028

111200000

usd

CY2022Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2029

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2029

19100000

usd

CY2022Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2030

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2030

7000000

usd

CY2022Q4

cno

Variable Interest Entity Amortized Cost Securities Held

VariableInterestEntityAmortizedCostSecuritiesHeld

1134200000

usd

CY2022Q4

cno

Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities

VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities

1000000

usd

CY2022Q4

cno

Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities

VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities

52100000

usd

CY2022Q4

cno

Variable Interest Entity Fixed Maturity Securities Allowance For Credit Loss

VariableInterestEntityFixedMaturitySecuritiesAllowanceForCreditLoss

5500000

usd

CY2022Q4

cno

Variable Interest Entity Fixed Maturity Securities Fair Value

VariableInterestEntityFixedMaturitySecuritiesFairValue

1077600000

usd

CY2022

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

8100000

usd

CY2022

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-6300000

usd

CY2022

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

-1800000

usd

CY2022

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

6300000

usd

CY2022

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

69200000

usd

CY2021

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

-3600000

usd

CY2021

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-7800000

usd

CY2021

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

11400000

usd

CY2021

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

8100000

usd

CY2021

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

70000000

usd

CY2020

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

13800000

usd

CY2020

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-8600000

usd

CY2020

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

-5200000

usd

CY2020

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

8700000

usd

CY2020

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

57400000

usd

CY2022Q4

cno

Numberof Variable Interest Entitiesin Default

NumberofVariableInterestEntitiesinDefault

0

investment

Name	View Source	Status
0001224608-23-000013-index-headers.html	Edgar Link	pending
0001224608-23-000013-index.html	Edgar Link	pending
0001224608-23-000013.txt	Edgar Link	pending
0001224608-23-000013-xbrl.zip	Edgar Link	pending
cno-20221231.htm	Edgar Link	pending
cno-20221231.xsd	Edgar Link	pending
cno-20221231_g1.jpg	Edgar Link	pending
cno12312022ex21.htm	Edgar Link	pending
cno-20221231_cal.xml	Edgar Link	unprocessable
cno-20221231_def.xml	Edgar Link	unprocessable
cno-20221231_lab.xml	Edgar Link	unprocessable
cno-20221231_pre.xml	Edgar Link	unprocessable
cno-20221231_htm.xml	Edgar Link	completed
cno12312022ex231.htm	Edgar Link	pending
cno12312022ex311.htm	Edgar Link	pending
cno12312022ex312.htm	Edgar Link	pending
cno12312022ex321.htm	Edgar Link	pending
cno12312022ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2023 Q1 Form 10-K Financial Statement

#000122460823000013 Filed on February 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2023 Q1 Form 10-K Financial Statement

#000122460823000013 Filed on February 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno